Skip to Content

9,407 Results Found

  • Feature Paper
  • Review
  • Open Access
103 Citations
13,825 Views
17 Pages

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective

  • Wayne Eskridge,
  • Donna R. Cryer,
  • Jörn M. Schattenberg,
  • Amalia Gastaldelli and ,
  • Harmeet Malhi,
  • Alina M. Allen,
  • Mazen Noureddin and
  • Arun J. Sanyal
  • + 3 authors+ 0 author

26 September 2023

Diagnosing and managing metabolic dysfunction-associated steatotic liver disease (MASLD) remains a major challenge in primary care due to lack of agreement on diagnostic tools, difficulty in identifying symptoms and determining their cause, absence o...

(This article belongs to the Special Issue Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current Concepts and Future Challenges)
  • Review
  • Open Access
37 Citations
9,050 Views
41 Pages

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis

  • Arun George Devasia,
  • Adaikalavan Ramasamy and
  • Chen Huei Leo

19 February 2025

In recent years, “metabolic dysfunction-associated steatotic liver disease” (MASLD) has been proposed to better connect liver disease to metabolic dysfunction, which is the most common chronic liver disease worldwide. MASLD affects more t...

(This article belongs to the Special Issue Diabetes and Its Complications: From Molecular Mechanisms to Novel Therapeutic Approaches)
  • Review
  • Open Access
39 Citations
8,994 Views
23 Pages

Immune and Metabolic Mechanisms of Endothelial Dysfunction

  • Irakli Kopaliani,
  • Basant Elsaid,
  • Stephan Speier and
  • Andreas Deussen

12 December 2024

Endothelial dysfunction is a strong prognostic factor in predicting the development of cardiovascular diseases. Dysfunctional endothelium loses its homeostatic ability to regulate vascular tone and prevent overactivation of inflammation, leading to v...

(This article belongs to the Special Issue Molecular Mechanisms of Endothelial Dysfunction: Fourth Edition)
  • Review
  • Open Access
21 Citations
8,062 Views
35 Pages

Epilepsy is a serious neurological disorder affecting around 70 million people globally and is characterized by spontaneous recurrent seizures. Recent evidence indicates that dysfunction in metabolic processes can lead to the alteration of neuronal a...

(This article belongs to the Section Pharmacology)
  • Feature Paper
  • Review
  • Open Access
10 Citations
4,326 Views
15 Pages

Update: Microdialysis for Monitoring Cerebral Metabolic Dysfunction after Subarachnoid Hemorrhage

  • Pierce Spencer,
  • Yinghua Jiang,
  • Ning Liu,
  • Jinrui Han and ,
  • Yadan Li,
  • Samuel Vodovoz,
  • Aaron S. Dumont and
  • Xiaoying Wang
  • + 3 authors+ 0 author

30 December 2020

Cerebral metabolic dysfunction has been shown to extensively mediate the pathophysiology of brain injury after subarachnoid hemorrhage (SAH). The characterization of the alterations of metabolites in the brain can help elucidate pathophysiological ch...

(This article belongs to the Special Issue Novel Approaches for the Treatment of Cerebrovascular Disorders)
  • Review
  • Open Access
16 Citations
5,496 Views
17 Pages

Currently, 30% of the global population is overweight or obese, with projections from the World Obesity Federation suggesting that this figure will surpass 50% by 2035. Adipose tissue dysfunction, a primary characteristic of obesity, is closely assoc...

(This article belongs to the Special Issue Recent Advances in Adipokines—2nd Edition)
  • Review
  • Open Access
16 Citations
5,262 Views
24 Pages

28 September 2023

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The management of PD is a challenging aspect for general physicians and neurologists. It is characterized by the progressive loss of dopaminergic neurons. Impaired...

(This article belongs to the Section Cell Biology)
  • Review
  • Open Access
8 Citations
4,956 Views
20 Pages

Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

  • Livhuwani P. Nendouvhada,
  • Nicole R. S. Sibuyi,
  • Adewale O. Fadaka,
  • Samantha Meyer and ,
  • Abram M. Madiehe,
  • Mervin Meyer and
  • Kwazikwakhe B. Gabuza
  • + 2 authors+ 0 author

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease, is a steatotic liver disease associated with metabolic syndrome (MetS), especially obesity, hypertension, diabetes, hyperlipidemia...

(This article belongs to the Section Bioactives and Nutraceuticals)
  • Review
  • Open Access
10 Citations
5,052 Views
22 Pages

30 December 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a multisystemic disease, i.e., influencing various organ systems beyond the liver and, thus, contributing to comorbidities. Characterized by excessive fat accumulation in the hepatoc...

(This article belongs to the Special Issue Retinal and Choroidal Vascular Disease)
  • Review
  • Open Access
73 Citations
14,650 Views
14 Pages

Aging-related salivary dysfunction commonly induces the poor oral health, including decreased saliva flow and dental caries. Although the clinical significance of the salivary glands is well-known, the complex metabolic pathways contributing to the a...

(This article belongs to the Special Issue Recent Advances in Salivary Gland and Their Function)
  • Review
  • Open Access
31 Citations
6,591 Views
14 Pages

Mitochondrial dysfunction and metabolic reprogramming have been extensively studied in many disorders ranging from cardiovascular to neurodegenerative disease. Obesity has previously been associated with mitochondrial fragmentation, dysregulated glyc...

(This article belongs to the Special Issue Mitochondrial Function in Human Health and Disease)
  • Review
  • Open Access
108 Citations
12,811 Views
19 Pages

Cancer Cachexia and Related Metabolic Dysfunction

  • Guilherme Wesley Peixoto da Fonseca,
  • Jerneja Farkas,
  • Eva Dora,
  • Stephan von Haehling and
  • Mitja Lainscak

Cancer cachexia is a complex multifactorial syndrome marked by a continuous depletion of skeletal muscle mass associated, in some cases, with a reduction in fat mass. It is irreversible by nutritional support alone and affects up to 74% of patients w...

(This article belongs to the Special Issue Cancer Cachexia and Related Metabolic Dysfunction)
  • Review
  • Open Access
35 Citations
8,371 Views
16 Pages

Metabolic Syndrome, Thyroid Dysfunction, and Cardiovascular Risk: The Triptych of Evil

  • Alessandro Pingitore,
  • Melania Gaggini,
  • Francesca Mastorci,
  • Laura Sabatino and ,
  • Linda Cordiviola and
  • Cristina Vassalle
  • + 1 author+ 0 author

2 October 2024

The triad formed by thyroid dysfunction, metabolic syndrome (MetS), and cardiovascular (CV) risk forms a network with many connections that aggravates health outcomes. Thyroid hormones (THs) play an important role in glucose and lipid metabolism and...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
7 Citations
1,812 Views
48 Pages

Background/Objectives: Metabolic-dysfunction-associated steatotic liver disease (MASLD) and metabolic-dysfunction-associated steatohepatitis (MASH) arise in the setting of obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. This rev...

(This article belongs to the Special Issue Exploring Pathological Mechanisms in Obesity, Diabetes, and Metabolic Syndrome: 2nd Edition)
  • Review
  • Open Access
59 Citations
7,680 Views
19 Pages

Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD), both of them accounting for fatty liver disease (FLD), are among the most common chronic liver diseases globally, contributing to substantial public health burden. Bot...

(This article belongs to the Special Issue 10th Anniversary of Biomedicines—NAFLD: From Mechanisms to Therapeutic Approaches)
  • Review
  • Open Access
2 Citations
2,926 Views
23 Pages

Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV: A Scoping Review

  • Vinay Jahagirdar,
  • Priyanka Parajuli,
  • Skylar Hargrove and
  • Richard K. Sterling

13 February 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease (NAFLD), has become a leading cause of chronic liver disease in people living with HIV (PLWH), especially in the era of effective an...

  • Review
  • Open Access
17 Citations
6,381 Views
18 Pages

Metabolic Dysfunction in Parkinson’s Disease: Unraveling the Glucose–Lipid Connection

  • Jeswinder Sian-Hulsmann,
  • Peter Riederer and
  • Tanja Maria Michel

13 December 2024

Despite many years of research into the complex neurobiology of Parkinson’s disease, the precise aetiology cannot be pinpointed down to one causative agent but rather a multitude of mechanisms. Current treatment options can alleviate symptomsbu...

(This article belongs to the Collection Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management)
  • Article
  • Open Access
4 Citations
1,216 Views
14 Pages

Adiposity and Metabolic Indices in the Diagnosis and Histological Stage Association of Metabolic Dysfunction-Associated Steatotic Liver Disease

  • Lorena del Rocio Ibarra-Reynoso,
  • Nemry Rodriguez-Hernandez,
  • Maria-Luisa Lazo-de-la-Vega-Monroy,
  • Juana Rosalba Garcia-Ramirez and ,
  • Yeniley Ruiz-Noa,
  • Benjamin Jordan-Perez,
  • Serafin Garnelo-Cabañas,
  • Veronica Muñoz-Cornejo and
  • Monica del Carmen Preciado-Puga
  • + 4 authors+ 0 author

25 November 2025

Background: Metabolic dysfunction-associated steatotic liver disease (MALSD) is defined as the excessive accumulation of triglycerides in the liver in the presence of at least one cardiometabolic risk factor and liver biopsy remains the diagnostic go...

(This article belongs to the Topic Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice, 2nd Edition)
  • Review
  • Open Access
95 Citations
13,532 Views
31 Pages

6 October 2025

Obesity contributes to the development of metabolic disorders such as type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) through sustained low-grade inflammation and mitochondrial dysfunction. In obes...

(This article belongs to the Special Issue Metabolic Syndrome: New Insights in Pathogenesis, Diagnosis, Prevention, and Management)
  • Review
  • Open Access
7 Citations
2,939 Views
18 Pages

Metabolic Dysfunction at the Core: Revisiting the Overlap of Cardiovascular, Renal, Hepatic, and Endocrine Disorders

  • Maria-Daniela Tanasescu,
  • Andrei-Mihnea Rosu,
  • Alexandru Minca,
  • Andreea-Liana Rosu and ,
  • Maria-Mihaela Grigorie,
  • Delia Timofte and
  • Dorin Ionescu
  • + 2 authors+ 0 author

20 January 2026

Metabolic dysfunction has emerged as a central driver of cardiovascular, renal, hepatic, and endocrine disorders, challenging traditional organ-specific disease models. Increasing evidence indicates that conditions such as obesity, type 2 diabetes, c...

(This article belongs to the Special Issue Advances in Vascular Health and Metabolism)
  • Article
  • Open Access
3 Citations
2,158 Views
25 Pages

Role of ChREBP–PPARα–FGF21 Axis in Metabolic Dysfunction of MASLD

  • Karina Mireya Palacios Girón,
  • Zamira Helena Hernandez Nazara,
  • Montserrat Maldonado-González,
  • Erika Martínez-López and ,
  • Martha P. Sánchez Muñoz,
  • Carlos Alfredo Bautista López,
  • Ma. Soledad Aldana Aguiñaga,
  • Jose Alfredo Dominguez-Rosales,
  • Belinda Vargas-Guerrero and
  • Bertha Ruíz-Madrigal
  • + 5 authors+ 0 author

26 November 2025

Metabolically Dysfunctional-Associated Steatotic Liver Disease (MASLD) affects both metabolically healthy obese (MHO) individuals and metabolically unhealthy lean (MUL) individuals. Key genes linked to liver dysfunction, such as MLXIPL, PPARA, and FG...

(This article belongs to the Special Issue Metabolic Dysfunction-Associated Steatotic Liver Disease: From Basic Science to Therapy)
  • Review
  • Open Access
43 Citations
7,165 Views
20 Pages

Mitochondrial Dysfunction Associated with mtDNA in Metabolic Syndrome and Obesity

  • Natalia Todosenko,
  • Olga Khaziakhmatova,
  • Vladimir Malashchenko,
  • Kristina Yurova and ,
  • Maria Bograya,
  • Maria Beletskaya,
  • Maria Vulf,
  • Natalia Gazatova and
  • Larisa Litvinova
  • + 4 authors+ 0 author

Metabolic syndrome (MetS) is a precursor to the major health diseases associated with high mortality in industrialized countries: cardiovascular disease and diabetes. An important component of the pathogenesis of the metabolic syndrome is mitochondri...

(This article belongs to the Special Issue Molecular Mechanisms of Metabolic Syndrome)
  • Review
  • Open Access
13 Citations
7,824 Views
16 Pages

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma

  • Melchor Alpízar Salazar,
  • Samantha Estefanía Olguín Reyes,
  • Andrea Medina Estévez,
  • Julieta Alejandra Saturno Lobos and ,
  • Jesús Manuel De Aldecoa Castillo,
  • Juan Carlos Carrera Aguas,
  • Samary Alaniz Monreal,
  • José Antonio Navarro Rodríguez and
  • Dulce María Fernanda Alpízar Sánchez
  • + 4 authors+ 0 author

7 January 2025

Introduction: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) stems from disrupted lipid metabolism in the liver, often linked to obesity, type 2 diabetes, and dyslipidemia. In Mexico, where obesity affects 36.9% of adults, MASLD pre...

(This article belongs to the Section Gastroenterology & Hepatology)
  • Review
  • Open Access
16 Citations
13,921 Views
21 Pages

28 October 2023

Metabolic dysfunction associated fatty liver disease (MAFLD) has been recently recognized as a new global chronic liver disease entity with non-alcoholic fatty liver disease (NAFLD) associated with overweight/obesity or type 2 diabetes mellitus (T2DM...

  • Article
  • Open Access
3 Citations
1,241 Views
21 Pages

APOC3 Promotes DGAT2-Dependent Triglyceride Accumulation in Hepatocytes During Early Metabolic Dysfunction

  • Thi Nhi Nguyen,
  • Hye-Jeong Kim,
  • Hye Min Shim,
  • Junho Kang and ,
  • Eun Young Ha,
  • Hochan Cho and
  • Jae-Hyung Park
  • + 2 authors+ 0 author

20 April 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by hepatic triglyceride accumulation in the setting of obesity and insulin resistance. Although apolipoprotein C-III (APOC3) is a well-established regulator of plasma t...

(This article belongs to the Special Issue Cellular Stress, Inflammation, and Metabolic Dysfunction in the Progression of MASLD)
  • Review
  • Open Access
44 Citations
12,700 Views
18 Pages

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models

  • Katarina Maksimovic,
  • Mohieldin Youssef,
  • Justin You,
  • Hoon-Ki Sung and
  • Jeehye Park

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons, leading to muscle weakness, paralysis, and eventual death. Research from the past few decades has appreciated that ALS is not only a disease of the motor n...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
15 Citations
4,796 Views
23 Pages

Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

  • Jelena Popov,
  • Tijana Despot,
  • David Avelar Rodriguez,
  • Irfan Khan and ,
  • Eugene Mech,
  • Mahrukh Khan,
  • Milan Bojadzija and
  • Nikhil Pai
  • + 3 authors+ 0 author

29 May 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent type of liver disease worldwide. The exact pathophysiology behind MASLD remains unclear; however, it is thought that a combination of factors or “hits”...

(This article belongs to the Special Issue Targeting the Gut Microbiota in Metabolic Disease)
  • Review
  • Open Access
160 Citations
16,566 Views
16 Pages

Obesity mediates most of its direct medical sequelae through the development of insulin resistance (IR). The cellular effects of insulin occur through two main postreceptor pathways that are the phosphatidylinositol 3-kinase (PI3-K) and the mitogen-a...

(This article belongs to the Special Issue Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction)
  • Review
  • Open Access
522 Views
26 Pages

15 September 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the predominant etiology of chronic liver disease and the leading factor to liver-related mortality. The endothelial dysfunction is a significant contributor to the onset of cardiova...

(This article belongs to the Special Issue Current Trends and Future Challenges in Hepatocellular Carcinoma)
  • Systematic Review
  • Open Access
9 Citations
3,228 Views
24 Pages

Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders

  • Sally Wu,
  • Kristoffer J. Panganiban,
  • Jiwon Lee,
  • Dan Li and ,
  • Emily C.C. Smith,
  • Kateryna Maksyutynska,
  • Bailey Humber,
  • Tariq Ahmed,
  • Sri Mahavir Agarwal and
  • Margaret Hahn
  • + 6 authors+ 1 author

28 August 2024

Metabolic dysfunction is commonly observed in schizophrenia spectrum disorders (SSDs). The causes of metabolic comorbidity in SSDs are complex and include intrinsic or biological factors linked to the disorder, which are compounded by antipsychotic (...

(This article belongs to the Section Metabolomic Profiling Technology)
  • Review
  • Open Access
16 Citations
6,146 Views
12 Pages

Namodenoson (CF102) is a small, orally available, anti-inflammatory, and anti-cancer drug candidate currently in phase 2B trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH; formerly known as non-alcoholic steatohepatit...

(This article belongs to the Special Issue NASH and Hepatocellular Carcinoma (HCC))
  • Review
  • Open Access
1 Citations
713 Views
20 Pages

Diet-Induced Ceramide Remodeling as a Mechanistic Link to Cardiac Metabolic Dysfunction

  • Manuela Giovanna Basilicata,
  • Lucia Scisciola,
  • Federico Capone,
  • Elisabetta Trevellin and ,
  • Pasquale Paolisso,
  • Marta Belmonte,
  • Ludovica Vittoria Marfella,
  • Martina Zanzillo,
  • Lorenzo Sabbatino and
  • Michelangela Barbieri
  • + 20 authors+ 15 authors

9 July 2026

Background/Objectives: Dietary patterns characterized by excess saturated fat intake contribute to obesity, type 2 diabetes, and cardiac metabolic dysfunction. Ceramides, bioactive sphingolipids synthesized in response to nutrient overload, have emer...

(This article belongs to the Special Issue Molecular Mechanisms of Diet-Associated Cardiac Metabolism)
  • Review
  • Open Access
60 Citations
30,150 Views
29 Pages

Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction

  • Aline Carla Inada,
  • Priscila Silva Figueiredo,
  • Rosângela Aparecida dos Santos-Eichler,
  • Karine De Cássia Freitas and ,
  • Priscila Aiko Hiane,
  • Alinne Pereira de Castro and
  • Rita De Cássia Avellaneda Guimarães
  • + 2 authors+ 0 author

25 May 2017

Cultural and economic shifts in the early 19th century led to the rapid development of companies that made good profits from technologically-produced commodities. In this way, some habits changed in society, such as the overconsumption of processed a...

  • Review
  • Open Access
61 Citations
18,713 Views
59 Pages

Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review

  • Muhammad Y. Sheikh,
  • Muhammad F. Younus,
  • Annie Shergill and
  • Muhammad N. Hasan

2 October 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), have become the leading causes of chronic liver disease worldwide, with increasing rates of cirrhosis,...

(This article belongs to the Special Issue Lifestyle Interventions in MASLD: Molecular and Clinical Perspectives)
  • Review
  • Open Access
35 Citations
5,856 Views
15 Pages

Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?

  • Marianne Riou,
  • Irina Enache,
  • François Sauer,
  • Anne-Laure Charles and
  • Bernard Geny

Pulmonary arterial hypertension (PAH) is a rare disease characterized by pulmonary vascular remodeling leading to right heart failure and death. To date, despite the three therapeutic approaches targeting the three major endothelial dysfunction pathw...

(This article belongs to the Special Issue Novel Therapeutic Targets for Pulmonary Arterial Hypertension)
  • Review
  • Open Access
1 Citations
2,495 Views
26 Pages

2 March 2026

Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic inflammatory disorder of the gastrointestinal tract with a rapidly increasing global prevalence. In parallel, metabolic comorbidities...

(This article belongs to the Special Issue Inflammatory Bowel Disease (IBD): Diagnosis and Personalized Treatment)
  • Review
  • Open Access
15 Citations
4,351 Views
32 Pages

Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma

  • Mahmoud Zhra,
  • Muhammad Affan Elahi,
  • Aamira Tariq,
  • Ahmed Abu-Zaid and
  • Ahmed Yaqinuddin

20 March 2025

Metabolic dysfunction leading to non-alcoholic fatty liver disease (NAFLD) exhibits distinct molecular and immune signatures that are influenced by factors like gut microbiota. The gut microbiome interacts with the liver via a bidirectional relations...

  • Review
  • Open Access
54 Citations
8,322 Views
15 Pages

Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors

  • Yoshihisa Takahashi,
  • Erdenetsogt Dungubat,
  • Hiroyuki Kusano and
  • Toshio Fukusato

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the livers of patients without a history of alcohol abuse. It is classified as either simple steatosis (nonalcoholic fatty liver) or nonalcoholic steatohepatit...

(This article belongs to the Special Issue NASH and Hepatocellular Carcinoma (HCC))
  • Review
  • Open Access
1 Citations
793 Views
15 Pages

Hepassocin (FGL-1) as a Hepatokine in Liver Physiology and Metabolic Dysfunction: A Narrative Review

  • Hung-Chih Chen,
  • Hiong-Ping Hii,
  • Kai-Pi Cheng,
  • Hung-Tsung Wu and ,
  • Hsin-Yu Kuo and
  • Horng-Yih Ou
  • + 1 author+ 0 author

Hepassocin, also known as fibrinogen-like protein 1 (FGL-1), is a liver-derived secretory protein initially identified as a mitogenic factor involved in hepatocyte proliferation and liver regeneration. Increasing evidence has subsequently suggested t...

(This article belongs to the Special Issue Molecular Insights into Chronic Liver Disease and Liver Failure)
  • Article
  • Open Access
9 Citations
4,306 Views
20 Pages

A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis—A Pilot Study

  • Thomai Mouskeftara,
  • Georgios Kalopitas,
  • Theodoros Liapikos,
  • Konstantinos Arvanitakis and ,
  • Eleni Theocharidou,
  • Georgios Germanidis and
  • Helen Gika
  • + 2 authors+ 0 author

5 December 2024

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common chronic liver disorder in Western countries, encompassing a range of conditions from steatosis to Metabolic Dysfunction-Associated Steatohepatitis (MASH), which can p...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
47 Citations
5,810 Views
14 Pages

Chronic inflammatory diseases are driven by persistent immune activation and metabolic imbalance that disrupt tissue homeostasis. Mitochondrial dysfunction disrupts cellular bioenergetics and immune regulation, driving persistent inflammatory signali...

(This article belongs to the Special Issue Molecular Mechanisms and Innovative Therapeutic Approaches in Inflammatory Diseases, Pioneering Precision Medicine Solutions)
  • Review
  • Open Access
16 Citations
4,378 Views
15 Pages

25 September 2024

Osteoarthritis (OA) is a prevalent joint disorder and the most common form of arthritis, affecting approximately 500 million people worldwide, or about 7% of the global population. Its pathogenesis involves a complex interplay between metabolic dysfu...

(This article belongs to the Special Issue Molecular Research on Osteoarthritis and Osteoporosis)
  • Review
  • Open Access
22 Citations
7,725 Views
22 Pages

25 December 2023

Melatonin (MT) has often been used to support good sleep quality, especially during the COVID-19 pandemic, as many have suffered from stress-related disrupted sleep patterns. It is less known that MT is an antioxidant, anti-inflammatory compound, and...

(This article belongs to the Special Issue Significance of Antioxidant Mechanisms in Intestinal Inflammation)
  • Review
  • Open Access
36 Citations
8,942 Views
25 Pages

Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis

  • Jiaxin Chen,
  • Linge Jian,
  • Yangkun Guo,
  • Chengwei Tang and ,
  • Zhiyin Huang and
  • Jinhang Gao
  • + 1 author+ 0 author

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately one-third of the global population. MASLD and its advanced-stage liver fibrosis and cirrhosis are the leading causes of liver failure and liver-related death world...

(This article belongs to the Special Issue Role of Oxidative Stress in Mitochondrial Function: Relevance for Liver Function)
  • Review
  • Open Access
24 Citations
7,730 Views
25 Pages

Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  • Federica Perazza,
  • Laura Leoni,
  • Beatrice Selvatici,
  • Francesca Girolami and ,
  • Alessia Bonalumi,
  • Alice Beretta,
  • Silvia Ferri,
  • Maria Letizia Petroni,
  • Fabio Piscaglia and
  • Michele Sculati
  • + 6 authors+ 1 author

1 June 2025

Gut microbiota has become an area of increasing interest for its potential role in metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced form, metabolic dysfunction-associated steatohepatitis (MASH)—now recogniz...

(This article belongs to the Section Clinical Nutrition)
  • Review
  • Open Access
12 Citations
19,750 Views
17 Pages

23 January 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the novel terminology encompassing liver disease associated with metabolic dysfunction, replacing the previous terminology of non-alcoholic fatty liver disease (NAFLD). This disease...

  • Review
  • Open Access
8 Citations
2,469 Views
20 Pages

The Interplay Between Cellular Senescence and Lipid Metabolism in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  • Eleftheria M. Mastoridou,
  • Anna C. Goussia,
  • Agapi Kataki,
  • Efthymios Koniaris and ,
  • Georgios K. Glantzounis,
  • Alexandra Papoudou-Bai,
  • Panagiotis Kanavaros and
  • Antonia V. Charchanti
  • + 3 authors+ 0 author

21 January 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is now recognized as the leading cause of chronic liver disease worldwide. MASLD spans a spectrum ranging from simple ste...

(This article belongs to the Special Issue Liver Fibrosis: Molecular Pathogenesis, Diagnosis and Treatment)
  • Review
  • Open Access
3 Citations
2,776 Views
18 Pages

Endocrine and Metabolic Modulation of Vascular Dysfunction in the Diabetic Foot: A Narrative Review

  • Luca Galassi,
  • Erica Altamura,
  • Elena Goldoni,
  • Gabriele Carioti and ,
  • Beatrice Faitelli,
  • Matteo Lino Ravini,
  • Niccolò Le Donne and
  • Kristi Nika
  • + 3 authors+ 0 author

Diabetic foot complications represent a major global health burden and arise from a multifactorial interaction between neuropathy, ischemia, infection, and impaired wound repair. Increasing evidence suggests that, beyond traditional vascular and meta...

(This article belongs to the Section Obesity, Diabetes Mellitus and Metabolic Syndrome)
  • Review
  • Open Access
54 Citations
9,693 Views
25 Pages

29 October 2018

Obstructive sleep apnea (OSA) is a highly prevalent worldwide public health problem that is characterized by repetitive upper airway collapse leading to intermittent hypoxia, pronounced negative intrathoracic pressures, and recurrent arousals resulti...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
3 Citations
1,642 Views
17 Pages

NDUFAB1 as a Novel Regulator of NEFA-Induced Metabolic Dysfunction in Bovine Adipocytes

  • Jing Zhou,
  • Tao Tang,
  • Wenqiang Sun,
  • Xianbo Jia and ,
  • Jie Wang,
  • Hengwei Yu and
  • Songjia Lai
  • + 2 authors+ 0 author

30 May 2025

Elevated non-esterified fatty acid (NEFA) levels are closely associated with metabolic disorders in dairy cattle, yet their direct effects on adipocyte physiology remain poorly understood. In this study, we demonstrate that high NEFA concentrations s...

(This article belongs to the Section Cattle)

of 189